Ourania Tatsis
CIK 1789815 · EVP, Chief Reg. & Quality Off. · last filed 2026-05-11
Ourania Tatsis is an EVP, Chief Reg. & Quality Off. who has filed 52 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for ODTX, was dated May 11, 2026. Across all open-market trades the lifetime net is −$20.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$20.92M
3
52
-$20.57M
Holdings By Company
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | ODTX | Grant (A) | — | $0 | EDGAR |
| 2026-02-26 | VRTX | Mixed | −1,887 | -$915.7K | EDGAR |
| 2026-02-19 | VRTX | Mixed | +2,518 | -$1.58M | EDGAR |
| 2026-02-18 | VRTX | Mixed | −5,304 | -$2.61M | EDGAR |
| 2026-02-12 | VRTX | Mixed | −2,606 | -$1.22M | EDGAR |
| 2026-01-26 | VRTX | Grant (A) | +11,749 | $0 | EDGAR |
| 2026-01-09 | VRTX | Sell (S) | −4,500 | -$2.14M | EDGAR |
| 2025-12-05 | VRTX | Sell (S) | −4,500 | -$2.02M | EDGAR |
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-06 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |